Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Organic Chemistry|October 18, 1996
Nickel-Catalyzed Preparations of Functionalized OrganozincsStephan Vettel, Andrea Vaupel, Paul Knochel
Bioorganic & Medicinal Chemistry Letters|August 24, 2005
Minor structural modifications convert a selective PPARalpha agonist into a potent, highly selective PPARdelta agonistStefan Weigand, Hilmar Bischoff, Elke Dittrich-Wengenroth, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Biphenyls as potent vitronectin receptor antagonistsKlaus Urbahns, Michael Härter, Markus Albers, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureasKlaus Urbahns, Michael Härter, Andrea Vaupel, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2014
Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interactionAndrea Vaupel, Guido Bold, Alain De Pover, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amidesKlaus Urbahns, Michael Härter, Markus Albers, et al.
Journal of Medicinal Chemistry|April 27, 2017
Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and AngiogenesisJuraj Velcicky, Wolfgang Miltz, Berndt Oberhauser, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2016
Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argumentPascal Furet, Keiichi Masuya, Joerg Kallen, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2018
In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitorAndrea Vaupel, Philipp Holzer, Stephane Ferretti, et al.
Pageof 2